Literature DB >> 24024499

Glomerular filtration rate estimated using creatinine, cystatin C or both markers and the risk of clinical events in HIV-infected individuals.

G M Lucas1, A Cozzi-Lepri, C M Wyatt, F A Post, A M Bormann, N F Crum-Cianflone, M J Ross.   

Abstract

OBJECTIVES: The accuracy and precision of glomerular filtration rate (GFR) estimating equations based on plasma creatinine (GFR(cr)), cystatin C (GFR(cys)) and the combination of these markers (GFR(cr-cys)) have recently been assessed in HIV-infected individuals. We assessed the associations of GFR, estimated by these three equations, with clinical events in HIV-infected individuals.
METHODS: We compared the associations of baseline GFR(cr), GFR(cys) and GFR(cr-cys) [using the Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) equations] with mortality, cardiovascular events (CVEs) and opportunistic diseases (ODs) in the Strategies for the Management of Antiretroviral Therapy (SMART) study. We used Cox proportional hazards models to estimate unadjusted and adjusted hazard ratios per standard deviation (SD) change in GFR.
RESULTS: A total of 4614 subjects from the SMART trial with available baseline creatinine and cystatin C data were included in this analysis. Of these, 99 died, 111 had a CVE and 121 had an OD. GFR(cys) was weakly to moderately correlated with HIV RNA, CD4 cell count, high-sensitivity C-reactive protein, interleukin-6, and D-dimer, while GFR(cr) had little or no correlation with these factors. GFR(cys) had the strongest associations with the three clinical outcomes, followed closely by GFR(cr-cys), with GFR(cr) having the weakest associations with clinical outcomes. In a model adjusting for demographics, cardiovascular risk factors, HIV-related factors and inflammation markers, a 1-SD lower GFR(cys) was associated with a 55% [95% confidence interval (CI) 27-90%] increased risk of mortality, a 21% (95% CI 0-47%) increased risk of CVE, and a 22% (95% CI 0-48%) increased risk of OD.
CONCLUSIONS: Of the three CKD-EPI GFR equations, GFR(cys) had the strongest associations with mortality, CVE and OD.
© 2013 British HIV Association.

Entities:  

Keywords:  HIV-1; cardiovascular disease; creatinine; cystatin C; glomerular filtration rate; mortality; opportunistic disease

Mesh:

Substances:

Year:  2013        PMID: 24024499      PMCID: PMC3947332          DOI: 10.1111/hiv.12087

Source DB:  PubMed          Journal:  HIV Med        ISSN: 1464-2662            Impact factor:   3.180


  24 in total

1.  Assessing kidney function--measured and estimated glomerular filtration rate.

Authors:  Lesley A Stevens; Josef Coresh; Tom Greene; Andrew S Levey
Journal:  N Engl J Med       Date:  2006-06-08       Impact factor: 91.245

2.  Plasma cystatin-C and development of coronary heart disease: The PRIME Study.

Authors:  Gérald Luc; Jean-Marie Bard; Céline Lesueur; Dominique Arveiler; Alun Evans; Philippe Amouyel; Jean Ferrieres; Irène Juhan-Vague; Jean-Charles Fruchart; Pierre Ducimetiere
Journal:  Atherosclerosis       Date:  2005-07-25       Impact factor: 5.162

Review 3.  Serum cystatin C as a marker of glomerular filtration rate.

Authors:  Magdalena Madero; Mark J Sarnak; Lesley A Stevens
Journal:  Curr Opin Nephrol Hypertens       Date:  2006-11       Impact factor: 2.894

Review 4.  Recommendations for improving serum creatinine measurement: a report from the Laboratory Working Group of the National Kidney Disease Education Program.

Authors:  Gary L Myers; W Greg Miller; Josef Coresh; James Fleming; Neil Greenberg; Tom Greene; Thomas Hostetter; Andrew S Levey; Mauro Panteghini; Michael Welch; John H Eckfeldt
Journal:  Clin Chem       Date:  2005-12-06       Impact factor: 8.327

5.  Estimating glomerular filtration rate from serum creatinine and cystatin C.

Authors:  Lesley A Inker; Christopher H Schmid; Hocine Tighiouart; John H Eckfeldt; Harold I Feldman; Tom Greene; John W Kusek; Jane Manzi; Frederick Van Lente; Yaping Lucy Zhang; Josef Coresh; Andrew S Levey
Journal:  N Engl J Med       Date:  2012-07-05       Impact factor: 91.245

6.  Risk for opportunistic disease and death after reinitiating continuous antiretroviral therapy in patients with HIV previously receiving episodic therapy: a randomized trial.

Authors:  W M El-Sadr; B Grund; J Neuhaus; A Babiker; C J Cohen; J Darbyshire; S Emery; J D Lundgren; A Phillips; J D Neaton
Journal:  Ann Intern Med       Date:  2008-09-02       Impact factor: 25.391

7.  Chronic kidney disease in HIV infection: an urban epidemic.

Authors:  Christina M Wyatt; Jonathan A Winston; Carlos D Malvestutto; Dawn A Fishbein; Irina Barash; Alan J Cohen; Mary E Klotman; Paul E Klotman
Journal:  AIDS       Date:  2007-10-01       Impact factor: 4.177

8.  CD4+ count-guided interruption of antiretroviral treatment.

Authors:  W M El-Sadr; J D Lundgren; J D Neaton; F Gordin; D Abrams; R C Arduino; A Babiker; W Burman; N Clumeck; C J Cohen; D Cohn; D Cooper; J Darbyshire; S Emery; G Fätkenheuer; B Gazzard; B Grund; J Hoy; K Klingman; M Losso; N Markowitz; J Neuhaus; A Phillips; C Rappoport
Journal:  N Engl J Med       Date:  2006-11-30       Impact factor: 91.245

9.  Inflammation, coagulation and cardiovascular disease in HIV-infected individuals.

Authors:  Daniel A Duprez; Jacqueline Neuhaus; Lewis H Kuller; Russell Tracy; Waldo Belloso; Stephane De Wit; Fraser Drummond; H Clifford Lane; Bruno Ledergerber; Jens Lundgren; Daniel Nixon; Nicholas I Paton; Ronald J Prineas; James D Neaton
Journal:  PLoS One       Date:  2012-09-10       Impact factor: 3.240

10.  Inflammatory and coagulation biomarkers and mortality in patients with HIV infection.

Authors:  Lewis H Kuller; Russell Tracy; Waldo Belloso; Stephane De Wit; Fraser Drummond; H Clifford Lane; Bruno Ledergerber; Jens Lundgren; Jacqueline Neuhaus; Daniel Nixon; Nicholas I Paton; James D Neaton
Journal:  PLoS Med       Date:  2008-10-21       Impact factor: 11.069

View more
  13 in total

1.  Reductions in Plasma Cystatin C After Initiation of Antiretroviral Therapy Are Associated With Reductions in Inflammation: ACTG A5224s.

Authors:  Chris T Longenecker; Douglas Kitch; Paul E Sax; Eric S Daar; Camlin Tierney; Samir K Gupta; Grace A McComsey
Journal:  J Acquir Immune Defic Syndr       Date:  2015-06-01       Impact factor: 3.731

Review 2.  Educational review: measurement of GFR in special populations.

Authors:  Guido Filler; Misan Lee
Journal:  Pediatr Nephrol       Date:  2017-12-07       Impact factor: 3.714

3.  Cross-Sectional and Longitudinal Performance of Creatinine- and Cystatin C-Based Estimating Equations Relative to Exogenously Measured Glomerular Filtration Rate in HIV-Positive and HIV-Negative Persons.

Authors:  Gregory M Lucas; Mohamed G Atta; Katie Zook; Dhananjay Vaidya; Xueting Tao; Paula Maier; George J Schwartz
Journal:  J Acquir Immune Defic Syndr       Date:  2020-12-01       Impact factor: 3.731

4.  Illness Perceptions, Medication Beliefs, and Adherence to Antiretrovirals and Medications for Comorbidities in Adults With HIV Infection and Hypertension or Chronic Kidney Disease.

Authors:  Jeffrey J Weiss; Ioannis Konstantinidis; Anna Boueilh; Daniel S Fierer; Donald Gardenier; Mark G Barber; Tony Kang; Anna Kress; Katherine Ericson; Marlene C Lira; Marina P Yostos; Hillary R Bogner; Juan P Wisnivesky; Christina M Wyatt
Journal:  J Acquir Immune Defic Syndr       Date:  2016-12-01       Impact factor: 3.731

5.  Novel Biomarkers of Cardiac Stress, Cardiovascular Dysfunction, and Outcomes in HIV-Infected Individuals.

Authors:  Eric A Secemsky; Rebecca Scherzer; Elaine Nitta; Alan H B Wu; David C Lange; Steven G Deeks; Jeffrey N Martin; James Snider; Peter Ganz; Priscilla Y Hsue
Journal:  JACC Heart Fail       Date:  2015-07-08       Impact factor: 12.035

6.  Kidney disease in the setting of HIV infection: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference.

Authors:  Charles R Swanepoel; Mohamed G Atta; Vivette D D'Agati; Michelle M Estrella; Agnes B Fogo; Saraladevi Naicker; Frank A Post; Nicola Wearne; Cheryl A Winkler; Michael Cheung; David C Wheeler; Wolfgang C Winkelmayer; Christina M Wyatt
Journal:  Kidney Int       Date:  2018-02-03       Impact factor: 10.612

7.  Impact of Age-related Comorbidities on Five-year Overall Mortality among Elderly HIV-Infected Patients in the Late HAART Era--Role of Chronic Renal Disease.

Authors:  M Hentzien; M Dramé; C Allavena; C Jacomet; M-A Valantin; A Cabié; L Cuzin; D Rey; P Pugliese; F Bani-Sadr
Journal:  J Nutr Health Aging       Date:  2016-04       Impact factor: 4.075

8.  Rosuvastatin preserves renal function and lowers cystatin C in HIV-infected subjects on antiretroviral therapy: the SATURN-HIV trial.

Authors:  Chris T Longenecker; Corrilynn O Hileman; Nicholas T Funderburg; Grace A McComsey
Journal:  Clin Infect Dis       Date:  2014-07-11       Impact factor: 9.079

9.  Estimation of renal function by three CKD-EPI equations in Chinese HIV/AIDS patients: A STROBE-compliant article.

Authors:  Naxin Zhao; Zhili Zeng; Hongyuan Liang; Fang Wang; Di Yang; Jiang Xiao; Meiling Chen; Hongxin Zhao; Fujie Zhang; Guiju Gao
Journal:  Medicine (Baltimore)       Date:  2021-06-04       Impact factor: 1.817

10.  Brief Report: Cystatin C-Based Estimation of Glomerular Filtration Rate and Association With Atherosclerosis Imaging Markers in People Living With HIV.

Authors:  Mitchell McClean; Petra Buzkova; Matthew Budoff; Michelle Estrella; Matthew Freiberg; Howard N Hodis; Frank Palella; Cecilia Shikuma; Wendy S Post; Samir Gupta
Journal:  J Acquir Immune Defic Syndr       Date:  2020-12-01       Impact factor: 3.771

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.